Local Institution - 0033

Tübingen 72076

1 studies enrolling now · 2 studies all time

What they study most

Prostate Cancer, Systemic Sclerosis

Studies at this site

• A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis — Starting soon
• A Study of Nivolumab Plus Ipilimumab, Ipilimumab Alone, or Cabazitaxel in Men With Metastatic Castration-Resistant Prostate Cancer (CheckMate 650) — Completed